<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01520155</url>
  </required_header>
  <id_info>
    <org_study_id>sleffm001</org_study_id>
    <nct_id>NCT01520155</nct_id>
  </id_info>
  <brief_title>CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)</brief_title>
  <acronym>CASTLE</acronym>
  <official_title>CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE): Studie Zur Detektion Des kardiovaskul√§ren Risikos in Patienten Mit Systemischem Lupus Erythematodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The key of this prospective study is to identify a potentially increased cardiovascular risk
      in patients with systemic Lupus erythematodes, with and without renal affection. Three groups
      of patients will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Key of this prospective study is to identify a potentially increased cardiovascular risk in
      patients with systemic Lupus erythematodes, with and without renal affection. Three group of
      patients will be compared as followed. First group are patients with known systemic Lupus
      erythematodes without renal affection, second group are patients with known systemic Lupus
      erythematodes with renal affection and the third group are patients with a non-autoimmun
      chronic kidney disease
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of cardiovascular risk in patients with systemic Lupus Erythematodes</measure>
    <time_frame>one year</time_frame>
    <description>Identification of cardiovascular risk in patients with systemic Lupus Erythematodes</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>Systemic lupus erythematosus with renal affection</arm_group_label>
    <description>30 patients will be investigated suffering from a known systemic lupus erythematosus with renal affection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic lupus erythematosus without renal affection</arm_group_label>
    <description>30 patients will be investigated suffering from a known systemic lupus erythematosus without renal affection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-autoimmune kidney disease</arm_group_label>
    <description>Patients with non-systemic, non-autoimmune kidney disease</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Every participant will provide 20 ml Serum for further laboratory analysis
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with or without systemic Lupus erythematosus
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systemic Lupus erythematosus

        Exclusion Criteria:

          -  Patients without systemic Lupus erythematosus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joachim R Ehrlich, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Frankfurt University Academic Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Frankfurt University Academic Medical Center</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2011</study_first_submitted>
  <study_first_submitted_qc>January 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2012</study_first_posted>
  <last_update_submitted>December 20, 2013</last_update_submitted>
  <last_update_submitted_qc>December 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Henrik Fox</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>lupus erythematosus</keyword>
  <keyword>cardiovascular risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

